TY - JOUR AB - Following the publication of the above article, the authors have requested a change in the authorship on the paper. The final author in the author list, Professor Akio Matsubara (of the Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University), contacted the Editorial Office to say that he should not have been listed as an author in this published article. His inclusion as an author on the paper arose as a misunderstanding on the part of some of the other authors. The revised authorship on the paper is shown above, now excluding Akio Matsubara. All the remaining authors agree with the revision made to the authorship on this paper, and the authors remaining on the paper apologize for any inconvenience caused. Therefore, the revised authors’ names and affiliations in this paper are as follows: Jun Teishima1, Daiki Murata2, Shogo Inoue1, Tetsutaro Hayashi1, Koji Mita2, Yasuhisa Hasegawa3, Masao Kato4, Mitsuru Kajiwara5, Masanobu Shigeta6, Satoshi Maruyama7, Hiroyuki Moriyama8 and Seiji Fujiwara9. 1Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734‑8551; 2Department of Urology, Hiroshima‑City Asa Citizens Hospital, Hiroshima 731‑0293; 3Department of Urology, Fukuyama Medical Center, Fukuyama, Hiroshima 720‑8520; 4Department of Urology, Hiroshima General Hospital, Hatsukaichi, Hiroshima 738‑8503; 5Department of Urology, Hiroshima Prefectural Hospital, Hiroshima 734‑8530; 6Department of Urology, Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima 737‑0023; 7Department of Urology, Miyoshi Central Hospital, Miyoshi, Tokushima 728‑8502; 8Department of Urology, Onomichi General Hospital, Onomichi, Hiroshima 722‑8508; 9Department of Urology, Higashi‑Hiroshima Medical Center, Higashi‑Hiroshima, Hiroshima 739‑0041, Japan. [the original article was published on Molecular and Clinical Oncology 12: 557‑564, 2020; DOI: 10.3892/mco.2020.2020] AD - Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734‑8551, Japan Department of Urology, Hiroshima‑City Asa Citizens Hospital, Hiroshima 731‑0293, Japan Department of Urology, Fukuyama Medical Center, Fukuyama, Hiroshima 720‑8520, Japan Department of Urology, Hiroshima General Hospital, Hatsukaichi, Hiroshima 738‑8503, Japan Department of Urology, Hiroshima Prefectural Hospital, Hiroshima 734‑8530, Japan Department of Urology, Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima 737‑0023, Japan Department of Urology, Miyoshi Central Hospital, Miyoshi, Tokushima 728‑8502, Japan Department of Urology, Onomichi General Hospital, Onomichi, Hiroshima 722‑8508, Japan Department of Urology, Higashi‑Hiroshima Medical Center, Higashi‑Hiroshima, Hiroshima 739‑0041, Japan AU - Teishima,Jun AU - Murata,Daiki AU - Inoue,Shogo AU - Hayashi,Tetsutaro AU - Mita,Koji AU - Hasegawa,Yasuhisa AU - Kato,Masao AU - Kajiwara,Mitsuru AU - Shigeta,Masanobu AU - Maruyama,Satoshi AU - Moriyama,Hiroyuki AU - Fujiwara,Seiji DA - 2021/08/01 DO - 10.3892/mco.2021.2317 IS - 2 JO - Mol Clin Oncol KW - metastatic renal cell carcinoma older-aged patients overall survival targeted therapy PY - 2021 SN - 2049-9450 2049-9469 SP - 155 ST - [Corrigendum] Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy T2 - Molecular and Clinical Oncology TI - [Corrigendum] Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy UR - https://doi.org/10.3892/mco.2021.2317 VL - 15 ER -